Immediate Impact
22 standout
Citing Papers
Osteoarthritis year in review 2024: Epidemiology and therapy
2024 Standout
New immune cell engagers for cancer immunotherapy
2024 Standout
Works of Longcheng Wang being referenced
OP0168 A phase 2a, placebo-controlled, randomized study of ABT-981, an anti-interleukin-1ALPHA and -1BETA dual variable domain immunoglobulin, to treat erosive hand osteoarthritis (EHOA)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Longcheng Wang | 5 | 6 | 5 | 8 | 6 | 3 | 25 | |
| Ryan Moslin | 6 | 2 | 3 | 4 | 3 | 21 | ||
| Ares Rocañín-Arjó | 10 | 3 | 3 | 11 | 3 | 32 | ||
| Christine Bellanné-Chantelot | 8 | 11 | 3 | 5 | 4 | 27 | ||
| Sidney H. Mandelbaum | 16 | 5 | 2 | 10 | 2 | 6 | 164 | |
| Nusayhah Hudaa Gopee | 9 | 7 | 3 | 2 | 3 | 31 | ||
| Claudine Sohn | 11 | 1 | 10 | 4 | 9 | 3 | 24 | |
| Kuan-Han H. Wu | 8 | 7 | 5 | 11 | 3 | 36 | ||
| Guillaume Bayer | 1 | 7 | 7 | 10 | 7 | 3 | 30 | |
| Lisa Worley | 4 | 4 | 2 | 6 | 2 | 29 | ||
| James McBurney | 8 | 1 | 9 | 2 | 19 | 2 | 37 |
All Works
Login with ORCID to disown or claim papers
Loading papers...